A sensitive and specific automatic biolumineseent method is described for glucose determination in senim samples using commercially available reagent-kits. The Boehringer Gluco-quant kit, originally designed for spectrophotometric measurement, was successfully coupled to the bacterial luciferase NAD(P)Hlinked System. The method's validity was proven by comparison with a spectrophotometric method. Correlation was excellent (r = 0.98, n = 50). Precision attained by 30 assays was good (CV 1.19%). The assay was verified by determining the glucose concentrations of more than 1000 serum samples.
Introduction
Luminescent assays are sensitive and specific. They are among the few methods with potential detection limits similar to those of radiochemical analysis. The bacterial NAD(P)H-linked luciferase System has long been regarded s an important potential replacement for conventional spectrophotometric indicator reactions in assays for Substrates of dehydrogenases. Somewhat surprisingly bacterial luciferase has not yet found the wide application that might be expected from its advantages, e. g. excellent sensivity, accuracy, precision, speed and convenience. A factor hampering the exploitation of the bacterial luciferase System was that only crude preparations of varying composition were commercially available until recently. Thus it was difficult to control the reaction and to predict or explain analytical differences. During the past few years purified enzymes have become available. Problems with the keeping properties of reagents, and with the techniques needed for measuring the kinetics of rapid light production have been resolved, or are at least considerably less severe than some years ago. Because of these improvements it should now be possible to couple reagent kits based on the enzymatic production of NADH or NADPH to the bacteriallinked luciferase System. This concept was tested with four commercially available reagent kits for glucose determination, originally designed for spectrophotometric measurements (Behring, Testomar; Boehringer Mannheim, Gluco-quant; Merck, Merckotest; Sigma, Glucose); all four kits were found to be suitable.
We present a fully automatic luminescence assay using the Boehringer Mannheim Gluco-quant kit and a microcomputer-controlled luminescence analyser (Berthold LB 950 T), which is at least 100 times more sensitive than the conventional method. Luminescent determination of glucose is particularly useful for analysis of neonatal blood, cerebrospinal fluid and other biological samples, which can only be obtained in small amounts. Furthermore, metabolic studies during physical exercise, using samples from a finger prick or ear-lobe puncture, are now possible. In addition, the method's high sensivity offers particular advantages for metabolic studies in single cells and various tissues. The Behring, Boehringer and Sigma kits are based on the hexokinase/glucose-6-phosphate dehydrogenase reaction and are coupled to NADPH (Behring, Boehringer) or NADHformation (Sigma) respectively. The Merck kit is based on the glucose dehydrogenase reaction and NADH formation. Control sera were from Behring Werke ("Kontrollogen L and LP"; glucose ssigned values 6mmol/l and 13-3 mmol/1) and from Boehringer (precimat glucose Standard 5.55 mmol/1).
Collection of blood
Samples were obtained by vein, flnger-prick or ear-lobe puncture. Samples (10 μΐ) of serum or plasma were diluted 100-150 times with deionized water.
Bioluminescent assay

Assay cocktail
Luciferase (1.5 U/l) and NAD(P)H : FMN oxidoreductase (1.7 kU/1) were dissolved in a potassium phosphate buffer (0.2 mol/1) containing 0.4 mmol/1 dithiothreitol and 67 mmol/1 raffinose. Tetradecanal (4.7 mmol/1) was dissolved in a solution containing 50 g/l bovine serum albumin, pH 7.0 at 50 °C. Solutions were divided into portions and stored at -20 °C. Flavin mononucleotide (FMN) (0.11 mmol/1) was dissolved in 0.2 mol/1 potassium phosphate (2 nmol/1, pH 7.0) and kept cool in a dark bottle. 100 ml of the assay cocktail consisted of: 50 ml potassium phosphate buffer containing dithiothreitol and raffinose, 10 ml tetradecanal solution, l ml FMN-, l ml luciferase-, 0.9 ml (NAD(P)H : FMN oxidoreductase solution and 32 ml deionized water. The final .concentrations were 0.5 nmol/1 tetradecanal, 1.1 μπιοΐ/l FMN, 15 mU/1 luciferase and 15.3 U/l NAD(P)H : FMN oxidoreductase.
The assay cocktail was prepared on a daily basis and kept cold on ice or in the refrigerator. Alternatively, commercially available bacterial luciferase reagent kits could be used. (Boehringer Mannheim, LKB Wallac, Lumac/3 M).
Preincubation (glucose conversion)
The components of each kit were dissolved accprding to the instructi ns for spectrophotometric measurements. The separate Solutions of each kit were mixed togethef to form the inc bation mixture recommended by the s ppliers. 20 μΐ of the diluted serum samples (l : 100-150) were pipetted into a cuvette and pl ced into an automatically moved chain. Enzymatic glucose conversion was initiated by automatic injection of 80 μΐ of the reconstituted reagent kit (Injectof Pos. 3). Samples passed through a temperature controlled inc bation chamber (25 °C) during the subsequent 5 minutes.
Materials and Methods
Chemicals
All luminescence enzymes and coenzymes were obtained from Boehringer Mannheim, West Germany. Tetradecanal and raffinose were from EGA Chemie, Steinheim, West Germany and from Sigma Chemicals, M nchen, West Germany respectively.
Measurements
C vettes containing 100 μΐ sample (20 μΐ diluted serum sample and 80 μΐ inc bation mixture) were automatically moved into the measuring position. Initiation of the Kght^producing reaction was triggered by automatic injection of 0.25 ml of assay cocktail (Injector Pos. 1). Glucose concentrations of samples were calculated using an external calibration curve. For Computer calculation a programme will be developed by the Firm of Berthold, Wildbad, West Germany.
Spectrophotometric assay
All Spectrophotometric measurements were performed according to the manufacturer's instructions. NAD(P)H determination was accomplished using a computer-controlled Beckmann DU 8 spectrophotometer.
Results
With the Gluco-quant reagents, conversion of glucose to NADPH was completed in 60 s, using a Standard solution (100 μιηοΐ/ΐ) with diluted serum samples (l: 100) ( fig. 1 ). Other tested kits (Behring, Merck, Sigma) showed similar conversion times. The NAD(P)H fonned was stable for at least 60 min. To test the stoichiometry of NADPH formation, light production (counts 10 3 /s) of a NADPH calibration curve and a glucose calibration curve was compared (fig. 4) . The experiment showed the NADPH calibration curve to be identical to that of the glucose calibration curve. 
Discussion
During the past few years the purity and stability of commercially available preparations of the NAD(P)H-linked bacterial luciferase System, including that of the Substrates and cofactors has been considerably improved. In ad^itiöh, autömatic instruments especiälly designed for luminometry are being öffered by several manüfactürers. With respect to the quality of reagents and Instrumentation, bioluminescent methods should now be easily applicable in routine clinical analysis, However, one difficulty in using luminescence assays in routine analysis in the clinical laboratory resides in the fact that none of the commercially available preparations of enzymes and coenzymes, which potentially can be coupled to luminescence, has been especiälly tested for impurities, which may cause either high blank readings, or interfere with light production during luminescent measurements.
Preparations of NAD, for instaüce, often contain large amounts of AMP which might interfere in assays coupled to the firefly luciferase System (1). We have recently published methods for the determina·* tion of glycerol and free fatty acids (2, 3, 4) ? Düe to unknown impurities of enzymes and coenzymes the NADH formed had to be diluted in order to reduce blank readings and to obtain a sufficiently wide dynamic ränge. This dilution Step precluded autömatic measurements. Similar problems might occur on coupling other dehydrogenase reactions to the bacterial NAD(P)H-linked luciferase System. In order to test this latter possibility, we have coupled reagent kits originally designed for spectrophotometric measurements of glucose in serum samples (Boehringer, Behring, Merck, Sigma) to the bacterial luciferase system. We thereby showed that the different commercially available reagent kits for glucose detennination are sufficiently pure to allow the fully autömatic bioluininescent determination of glucose. The Boehringer Gluco-quant kit shows a favourable signäl to noise ratio äs well äs a wide dynamic ränge. We were therefore able to couple the reagent kit to the bioluminescent system without further dilution öf the NADPH formed. The principle of coupling conventional reagent kits to a bioluminescent method is also applicable to other commercially available preparat ions for spectrophotometric glucose detenrtinations (Behring, Merck, Sigma). Due to their low blank readings and their favourable dynamic ränge (2 -100 / ) the Behring and the Merck kits can also be fully atitomated in the same way äs the Boehringer kit. The Sigma kit, however, was less suitable for automatipn with respect to its t detection limit and dynamic ränge (4 -30 Using the bioluminescent approach, the reagent kits are at least 100 times more sensitive than spectro photometric methods. Precision and accuracy of the method meet the demands for routine analysis in clinical cheinistry. Due to the relatively high dihition (100 -150-fold) of native samples, treatment with the fluoride, usually performed to inhibit glycolysis, did not interfere with the bioluminescent signal. For the same reason, the samples were not treated with acid to stop possible NAD(P)H degradation by interfering serum dehydrogenases, Using reagent kits for luminometry (LKB Wallac, Lumac/3 M, Boehringer Mannheim) and reagent kits for spectrophotometric glucose determination, the complete assay can be performed with commercially available reagents. A laboratory-internal assay cocktail was produced which reduced costs by approximately 90% when compared with commercially available luciferase reagent kits. A number of other highly sensitive methods for the luminescent determination of glucose have been published (5 -8) . All these assays, either bioluminescent or chemiluminescent, are poorly applicable to routine analysis in the clinical laboratory. The bioluminescent method of Brolin et al. (5) was published at a time when only crude preparations of the bacterial NAD(P)H-linked luciferase System were available. For that reason it has never been validated on a reliable number of actual samples. The method based on the immobilized bacterial luciferase System (6) has the disadvantage of not being available commercially, äs well äs requiring special equipment. The chemiluminescent methods (7, 8 ) based on glucose oxidation and H 2 O 2 formation cannot be applied to untreated biological samples.
The method presented here offers considerable advantages for the clinical laboratory. Because of its high sensivity only a few microliters of a sample are needed for each determination. In addition, it is automatic and completely based on commercially available reagents and test combinations.
In summary, this report shows that in contrast to luminescent immunoassays (LIA), which are not yet available äs kits ready for use, the bioluminescent measurement of Substrates is already suitable for routine application in clinical chemistry. By coupling conventional reagent kits to the bacterial luciferase System, bioluminescence is a reliable and highly sensitive tool for the determination of a wide ränge of serum components, provided that the reagents are selected which give an optimal dynamic ränge (signal to noise ratio).
